US Stock MarketDetailed Quotes

Centessa Pharmaceuticals (CNTA)

Watchlist
  • 25.470
  • +0.820+3.33%
Trading Jan 23 15:42 ET
3.72BMarket Cap-13.48P/E (TTM)

Centessa Pharmaceuticals (CNTA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
22.06%-37.29M
20.05%-160.34M
39.78%-31.05M
Net income from continuing operations
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
Operating gains losses
----
----
----
--34.1M
----
----
----
----
----
----
Depreciation and amortization
0.42%237K
-4.24%226K
-9.58%217K
16.30%942K
-6.50%230K
-0.84%236K
-0.42%236K
169.66%240K
518.32%810K
583.33%246K
Deferred tax
-79.67%255K
80.95%1.03M
129.26%995K
110.00%2.65M
367.11%398K
143.39%1.25M
102.41%567K
--434K
-828.56%-26.53M
94.63%-149K
Other non cash items
--271K
--190K
--415K
121.43%62K
-150.75%-168K
----
----
----
-83.82%28K
---67K
Change In working capital
-195.43%-11.26M
415.63%18.55M
-320.36%-38.54M
217.20%22.1M
851.38%25.34M
365.50%11.8M
-21.55%-5.88M
-47.80%-9.17M
-566.13%-18.86M
75.98%-3.37M
-Change in receivables
-201.42%-9.98M
293.07%10.73M
-454.26%-4.28M
45.41%-6.6M
-52.43%-12.1M
523.90%9.84M
9.49%-5.56M
-71.92%1.21M
-3.25%-12.09M
-105.36%-7.94M
-Change in prepaid assets
-198.08%-3.94M
414.66%4.7M
-183.31%-2.68M
849.19%10.22M
143.04%4.49M
261.77%4.01M
17.23%-1.49M
199.07%3.21M
63.45%-1.36M
123.26%1.85M
-Change in payables and accrued expense
221.93%2.59M
178.25%3.06M
-131.58%-31.65M
616.79%18.19M
1,150.08%32.88M
-1,023.91%-2.13M
-78.88%1.1M
-17.97%-13.67M
-127.90%-3.52M
217.52%2.63M
-Change in other current assets
-14.86%63K
-16.00%63K
-14.47%65K
115.83%298K
-14.12%73K
-41.27%74K
103.58%75K
--76K
---1.88M
--85K
Cash from discontinued investing activities
Operating cash flow
-172.63%-58.31M
44.67%-22.45M
-53.53%-57.25M
11.40%-142.06M
-37.84%-42.8M
42.80%-21.39M
7.90%-40.58M
22.06%-37.29M
20.05%-160.34M
39.78%-31.05M
Investing cash flow
Cash flow from continuing investing activities
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
119.41%16.76M
-13,541.68%-127M
-3,997.53%-18.28M
Net PPE purchase and sale
-588.24%-234K
----
----
79.88%-34K
--0
20.93%-34K
--0
--0
85.14%-169K
95.71%-28K
Net investment purchase and sale
38.18%62.18M
28.18%-39.83M
-1,426.74%-222.39M
124.68%31.3M
237.01%25M
-7.69%45M
21.99%-55.46M
119.43%16.76M
---126.84M
---18.25M
Cash from discontinued investing activities
Investing cash flow
37.77%61.95M
27.96%-39.95M
-1,426.74%-222.39M
124.62%31.27M
236.80%25M
-7.68%44.96M
22.00%-55.46M
119.41%16.76M
-13,541.68%-127M
-3,997.53%-18.28M
Financing cash flow
Cash flow from continuing financing activities
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
10.49M
4,520.79%21.12M
7,047.19%6.36M
Net issuance payments of debt
----
----
----
---762K
----
----
----
----
--0
----
Net common stock issuance
--0
--0
-36.73%6.11M
1,628.29%359.61M
-100.48%-30K
1,566.49%242.71M
--107.27M
--9.66M
--20.81M
--6.24M
Proceeds from stock option exercised by employees
-16.09%3.56M
112.59%1.71M
110.38%1.76M
3,521.61%11.23M
4,427.12%5.34M
2,258.33%4.25M
6,583.33%802K
--838K
-56.82%310K
32.58%118K
Net other financing activities
87.11%-125K
---100K
---4.79M
---5.32M
---1.59M
---970K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-98.60%3.44M
-98.48%1.61M
-70.59%3.09M
1,627.29%364.75M
-53.42%2.96M
1,568.36%245.98M
877,508.33%105.31M
--10.49M
4,520.79%21.12M
7,047.19%6.36M
Net cash flow
Beginning cash position
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
-67.48%128.03M
130.34%395.03M
-12.29%127.37M
-54.53%118.22M
-67.48%128.03M
-33.85%393.64M
-61.45%171.5M
Current changes in cash
-97.38%7.07M
-755.61%-60.8M
-2,656.93%-276.55M
195.39%253.96M
65.47%-14.84M
934.45%269.56M
108.05%9.27M
92.52%-10.03M
-32.44%-266.23M
17.25%-42.96M
Effect of exchange rate changes
73.69%-501K
5.83%-113K
-792.69%-1.52M
99.51%1.23M
701.59%3.03M
-965.45%-1.9M
-131.50%-120K
-57.72%219K
247.13%615K
-169.81%-504K
End cash Position
-87.14%50.81M
-65.27%44.24M
-11.05%105.16M
199.32%383.22M
199.32%383.22M
130.34%395.03M
-12.29%127.37M
-54.53%118.22M
-67.48%128.03M
-67.48%128.03M
Free cash flow
-173.29%-58.55M
44.36%-22.58M
-53.53%-57.25M
11.48%-142.09M
-37.72%-42.8M
42.77%-21.42M
7.92%-40.58M
22.20%-37.29M
20.41%-160.51M
40.48%-31.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M22.06%-37.29M20.05%-160.34M39.78%-31.05M
Net income from continuing operations -28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M
Operating gains losses --------------34.1M------------------------
Depreciation and amortization 0.42%237K-4.24%226K-9.58%217K16.30%942K-6.50%230K-0.84%236K-0.42%236K169.66%240K518.32%810K583.33%246K
Deferred tax -79.67%255K80.95%1.03M129.26%995K110.00%2.65M367.11%398K143.39%1.25M102.41%567K--434K-828.56%-26.53M94.63%-149K
Other non cash items --271K--190K--415K121.43%62K-150.75%-168K-------------83.82%28K---67K
Change In working capital -195.43%-11.26M415.63%18.55M-320.36%-38.54M217.20%22.1M851.38%25.34M365.50%11.8M-21.55%-5.88M-47.80%-9.17M-566.13%-18.86M75.98%-3.37M
-Change in receivables -201.42%-9.98M293.07%10.73M-454.26%-4.28M45.41%-6.6M-52.43%-12.1M523.90%9.84M9.49%-5.56M-71.92%1.21M-3.25%-12.09M-105.36%-7.94M
-Change in prepaid assets -198.08%-3.94M414.66%4.7M-183.31%-2.68M849.19%10.22M143.04%4.49M261.77%4.01M17.23%-1.49M199.07%3.21M63.45%-1.36M123.26%1.85M
-Change in payables and accrued expense 221.93%2.59M178.25%3.06M-131.58%-31.65M616.79%18.19M1,150.08%32.88M-1,023.91%-2.13M-78.88%1.1M-17.97%-13.67M-127.90%-3.52M217.52%2.63M
-Change in other current assets -14.86%63K-16.00%63K-14.47%65K115.83%298K-14.12%73K-41.27%74K103.58%75K--76K---1.88M--85K
Cash from discontinued investing activities
Operating cash flow -172.63%-58.31M44.67%-22.45M-53.53%-57.25M11.40%-142.06M-37.84%-42.8M42.80%-21.39M7.90%-40.58M22.06%-37.29M20.05%-160.34M39.78%-31.05M
Investing cash flow
Cash flow from continuing investing activities 37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M119.41%16.76M-13,541.68%-127M-3,997.53%-18.28M
Net PPE purchase and sale -588.24%-234K--------79.88%-34K--020.93%-34K--0--085.14%-169K95.71%-28K
Net investment purchase and sale 38.18%62.18M28.18%-39.83M-1,426.74%-222.39M124.68%31.3M237.01%25M-7.69%45M21.99%-55.46M119.43%16.76M---126.84M---18.25M
Cash from discontinued investing activities
Investing cash flow 37.77%61.95M27.96%-39.95M-1,426.74%-222.39M124.62%31.27M236.80%25M-7.68%44.96M22.00%-55.46M119.41%16.76M-13,541.68%-127M-3,997.53%-18.28M
Financing cash flow
Cash flow from continuing financing activities -98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M10.49M4,520.79%21.12M7,047.19%6.36M
Net issuance payments of debt ---------------762K------------------0----
Net common stock issuance --0--0-36.73%6.11M1,628.29%359.61M-100.48%-30K1,566.49%242.71M--107.27M--9.66M--20.81M--6.24M
Proceeds from stock option exercised by employees -16.09%3.56M112.59%1.71M110.38%1.76M3,521.61%11.23M4,427.12%5.34M2,258.33%4.25M6,583.33%802K--838K-56.82%310K32.58%118K
Net other financing activities 87.11%-125K---100K---4.79M---5.32M---1.59M---970K----------------
Cash from discontinued financing activities
Financing cash flow -98.60%3.44M-98.48%1.61M-70.59%3.09M1,627.29%364.75M-53.42%2.96M1,568.36%245.98M877,508.33%105.31M--10.49M4,520.79%21.12M7,047.19%6.36M
Net cash flow
Beginning cash position -65.27%44.24M-11.05%105.16M199.32%383.22M-67.48%128.03M130.34%395.03M-12.29%127.37M-54.53%118.22M-67.48%128.03M-33.85%393.64M-61.45%171.5M
Current changes in cash -97.38%7.07M-755.61%-60.8M-2,656.93%-276.55M195.39%253.96M65.47%-14.84M934.45%269.56M108.05%9.27M92.52%-10.03M-32.44%-266.23M17.25%-42.96M
Effect of exchange rate changes 73.69%-501K5.83%-113K-792.69%-1.52M99.51%1.23M701.59%3.03M-965.45%-1.9M-131.50%-120K-57.72%219K247.13%615K-169.81%-504K
End cash Position -87.14%50.81M-65.27%44.24M-11.05%105.16M199.32%383.22M199.32%383.22M130.34%395.03M-12.29%127.37M-54.53%118.22M-67.48%128.03M-67.48%128.03M
Free cash flow -173.29%-58.55M44.36%-22.58M-53.53%-57.25M11.48%-142.09M-37.72%-42.8M42.77%-21.42M7.92%-40.58M22.20%-37.29M20.41%-160.51M40.48%-31.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More